EXCHANGE AGREEMENTExchange Agreement • October 15th, 2024 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus • Delaware
This Exchange Agreement (this “Agreement”) is dated as of October 10, 2024, by and among Interpace Biosciences, Inc., a Delaware corporation (the “Company”), 1315 Capital II, L.P., a Delaware limited partnership (including its successors and assigns, “1315 Capital”) and Ampersand 2018 Limited Partnership, a Delaware limited partnership (including its successors and assigns, “Ampersand” and, together with 1315 Capital, the “Preferred Stockholders” and each a “Preferred Stockholder”).
AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTAddendum Agreement • October 15th, 2024 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus • Delaware
THIS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (this “Agreement”) is entered into as of October 10, 2024, by and among Interpace Biosciences, Inc., a Delaware corporation (the “Company”), 1315 Capital II, L.P., a Delaware limited partnership (including its successors and assigns, “1315 Capital”) and Ampersand 2018 Limited Partnership, a Delaware limited partnership (including its successors and assigns, “Ampersand” and, together with 1315 Capital, the “Investors” and each an “Investor”).
TERMINATION OF SUPPORT AGREEMENTTermination of Support Agreement • October 15th, 2024 • Interpace Biosciences, Inc. • Surgical & medical instruments & apparatus • Delaware
WHEREAS, the Company and 1315 Capital entered into that certain Support Agreement, dated as of January 15, 2020 (the “Support Agreement”).
